We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

260 hedge funds and large institutions have $6.22B invested in Alnylam Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 98 increasing their positions, 75 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 75

18% more capital invested

Capital invested by funds: $5.26B → $6.22B (+$960M)

13% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 39

1% more funds holding

Funds holding: 257 → 260 (+3)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

17% less call options, than puts

Call options by funds: $21M | Put options by funds: $25.4M

Holders
260
Holders Change
+3
Holders Change %
+1.17%
% of All Funds
6.82%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.18%
New
44
Increased
98
Reduced
75
Closed
39
Calls
$21M
Puts
$25.4M
Net Calls
-$4.4M
Net Calls Change
-$20.5M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$187M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$38.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.9M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$14.7M
5
SPC
Slate Path Capital
New York
+$12.1M

Top Sellers

1
AAMU
Amundi Asset Management US
Massachusetts
-$50.8M
2
First Trust Advisors
First Trust Advisors
Illinois
-$31.4M
3
UIM
USS Investment Management
United Kingdom
-$22.2M
4
CCM
Camber Capital Management
Massachusetts
-$20.1M
5
GTP
Global Thematic Partners
New York
-$18.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$42.2M +$962K +10,371 +2%
BG
27
BlackRock Group
United Kingdom
$40.1M +$972K +10,479 +3%
Invesco
28
Invesco
Georgia
$37.5M -$12.6M -135,504 -25%
Goldman Sachs
29
Goldman Sachs
New York
$37M +$6.25M +67,369 +21%
Northern Trust
30
Northern Trust
Illinois
$32M -$6.19M -66,757 -16%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$29.4M -$670K -7,223 -2%
Legal & General Group
32
Legal & General Group
United Kingdom
$27.2M +$984K +10,609 +4%
Deutsche Bank
33
Deutsche Bank
Germany
$25.1M -$10.4M -112,568 -30%
CAM
34
Cormorant Asset Management
Massachusetts
$23.1M +$9.74M +105,000 +75%
Artisan Partners
35
Artisan Partners
Wisconsin
$22.4M -$638K -6,881 -3%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$21.2M +$1.78M +19,154 +9%
Mitsubishi UFJ Trust & Banking
37
Mitsubishi UFJ Trust & Banking
Japan
$20.8M +$6.79M +73,183 +49%
AQR Capital Management
38
AQR Capital Management
Connecticut
$20.4M +$5.83M +62,887 +41%
Sumitomo Mitsui Trust Group
39
Sumitomo Mitsui Trust Group
Japan
$19.1M +$451K +4,865 +2%
TCIM
40
TIAA CREF Investment Management
New York
$18.9M -$1.96M -21,107 -10%
VanEck Associates
41
VanEck Associates
New York
$18.3M +$3.99M +43,021 +29%
CS
42
Credit Suisse
Switzerland
$17.8M -$1.63M -17,580 -8%
Citadel Advisors
43
Citadel Advisors
Florida
$17.1M +$3.9M +42,110 +30%
BA
44
BlackRock Advisors
Delaware
$16.9M +$1.26M +13,612 +8%
TRSOTSOK
45
Teachers Retirement System of the State of Kentucky
Kentucky
$16.8M +$1.08M +11,680 +7%
ACH
46
ArrowMark Colorado Holdings
Colorado
$16.6M +$14.7M +159,081 +904%
FC
47
FIC Capital
New York
$15.5M +$240K +2,589 +2%
TCM
48
TimesSquare Capital Management
New York
$15.1M -$1.78M -19,150 -11%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$13.8M – – –
Swiss National Bank
50
Swiss National Bank
Switzerland
$13M +$315K +3,400 +3%
1
2
3 4 5

ALNY Hedge Fund Activity: Q4 2015 in Review

260 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q4 2015, worth a combined $6.22B — up 18% from $5.26B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ALNY positions and 39 closed out — a net gain of 5 holders — while 98 added to existing stakes and 75 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $187M. The largest seller was Amundi Asset Management US, exiting entirely with an estimated $50.8M sold.

  • 260 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q4 2015, up from 257 in Q3 2015.
  • Funds reported $6.22B of Alnylam Pharmaceuticals stock for Q4 2015, up 18% quarter-over-quarter.
  • 44 funds opened new Alnylam Pharmaceuticals positions in Q4 2015 and 39 closed out, a net change of +5 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q4 2015 was Baillie Gifford & Co, an estimated $187M added.
  • The largest Alnylam Pharmaceuticals seller in Q4 2015 was Amundi Asset Management US, an estimated $50.8M sold.

Based on aggregated 13F filings for Q4 2015.